Leveraging physiologically‐based pharmacokinetic ( PBPK) modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients. Salerno, S. N, Capparelli, E. V, McIlleron, H., Gerhart, J. G, Dumond, J. B, Kashuba, A. D M, Denti, P., & Gonzalez, D. Pharmacotherapy, John Wiley & Sons, Ltd, may, 2022. Paper doi bibtex @article{Salerno2022,
author = {Salerno, Sara N and Capparelli, Edmund V and McIlleron, Helen and Gerhart, Jacqueline G and Dumond, Julie B and Kashuba, Angela D M and Denti, Paolo and Gonzalez, Daniel},
doi = {10.1002/phar.2703},
issn = {0277-0008},
journal = {Pharmacotherapy},
keywords = {OA,based pharmacokinetic modeling (PBPK),drug,drug interactions (DDI),fund{\_}not{\_}ack,human immunodeficiency virus (HIV),lopinavir (LPV),original,pediatric,physiologically,rifampicin,ritonavir (RTV),tuberculosis (TB)},
mendeley-tags = {OA,fund{\_}not{\_}ack,original},
month = {may},
pmid = {35607886},
publisher = {John Wiley {\&} Sons, Ltd},
title = {{Leveraging physiologically‐based pharmacokinetic ( PBPK) modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients}},
url = {https://onlinelibrary.wiley.com/doi/full/10.1002/phar.2703 https://onlinelibrary.wiley.com/doi/abs/10.1002/phar.2703 https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2703 https://onlinelibrary.wiley.com/doi/10.1002/phar.2703},
year = {2022}
}
Downloads: 0
{"_id":"Tr8AqPTLp29RJdpZG","bibbaseid":"salerno-capparelli-mcilleron-gerhart-dumond-kashuba-denti-gonzalez-leveragingphysiologicallybasedpharmacokineticpbpkmodelingtooptimizedosingforlopinavirritonavirwithrifampininpediatricpatients-2022","author_short":["Salerno, S. N","Capparelli, E. V","McIlleron, H.","Gerhart, J. G","Dumond, J. B","Kashuba, A. D M","Denti, P.","Gonzalez, D."],"bibdata":{"bibtype":"article","type":"article","author":[{"propositions":[],"lastnames":["Salerno"],"firstnames":["Sara","N"],"suffixes":[]},{"propositions":[],"lastnames":["Capparelli"],"firstnames":["Edmund","V"],"suffixes":[]},{"propositions":[],"lastnames":["McIlleron"],"firstnames":["Helen"],"suffixes":[]},{"propositions":[],"lastnames":["Gerhart"],"firstnames":["Jacqueline","G"],"suffixes":[]},{"propositions":[],"lastnames":["Dumond"],"firstnames":["Julie","B"],"suffixes":[]},{"propositions":[],"lastnames":["Kashuba"],"firstnames":["Angela","D","M"],"suffixes":[]},{"propositions":[],"lastnames":["Denti"],"firstnames":["Paolo"],"suffixes":[]},{"propositions":[],"lastnames":["Gonzalez"],"firstnames":["Daniel"],"suffixes":[]}],"doi":"10.1002/phar.2703","issn":"0277-0008","journal":"Pharmacotherapy","keywords":"OA,based pharmacokinetic modeling (PBPK),drug,drug interactions (DDI),fund_not_ack,human immunodeficiency virus (HIV),lopinavir (LPV),original,pediatric,physiologically,rifampicin,ritonavir (RTV),tuberculosis (TB)","mendeley-tags":"OA,fund_not_ack,original","month":"may","pmid":"35607886","publisher":"John Wiley & Sons, Ltd","title":"Leveraging physiologically‐based pharmacokinetic ( PBPK) modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients","url":"https://onlinelibrary.wiley.com/doi/full/10.1002/phar.2703 https://onlinelibrary.wiley.com/doi/abs/10.1002/phar.2703 https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2703 https://onlinelibrary.wiley.com/doi/10.1002/phar.2703","year":"2022","bibtex":"@article{Salerno2022,\r\nauthor = {Salerno, Sara N and Capparelli, Edmund V and McIlleron, Helen and Gerhart, Jacqueline G and Dumond, Julie B and Kashuba, Angela D M and Denti, Paolo and Gonzalez, Daniel},\r\ndoi = {10.1002/phar.2703},\r\nissn = {0277-0008},\r\njournal = {Pharmacotherapy},\r\nkeywords = {OA,based pharmacokinetic modeling (PBPK),drug,drug interactions (DDI),fund{\\_}not{\\_}ack,human immunodeficiency virus (HIV),lopinavir (LPV),original,pediatric,physiologically,rifampicin,ritonavir (RTV),tuberculosis (TB)},\r\nmendeley-tags = {OA,fund{\\_}not{\\_}ack,original},\r\nmonth = {may},\r\npmid = {35607886},\r\npublisher = {John Wiley {\\&} Sons, Ltd},\r\ntitle = {{Leveraging physiologically‐based pharmacokinetic ( PBPK) modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients}},\r\nurl = {https://onlinelibrary.wiley.com/doi/full/10.1002/phar.2703 https://onlinelibrary.wiley.com/doi/abs/10.1002/phar.2703 https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2703 https://onlinelibrary.wiley.com/doi/10.1002/phar.2703},\r\nyear = {2022}\r\n}\r\n","author_short":["Salerno, S. N","Capparelli, E. V","McIlleron, H.","Gerhart, J. G","Dumond, J. B","Kashuba, A. D M","Denti, P.","Gonzalez, D."],"key":"Salerno2022","id":"Salerno2022","bibbaseid":"salerno-capparelli-mcilleron-gerhart-dumond-kashuba-denti-gonzalez-leveragingphysiologicallybasedpharmacokineticpbpkmodelingtooptimizedosingforlopinavirritonavirwithrifampininpediatricpatients-2022","role":"author","urls":{"Paper":"https://onlinelibrary.wiley.com/doi/full/10.1002/phar.2703 https://onlinelibrary.wiley.com/doi/abs/10.1002/phar.2703 https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2703 https://onlinelibrary.wiley.com/doi/10.1002/phar.2703"},"keyword":["OA","based pharmacokinetic modeling (PBPK)","drug","drug interactions (DDI)","fund_not_ack","human immunodeficiency virus (HIV)","lopinavir (LPV)","original","pediatric","physiologically","rifampicin","ritonavir (RTV)","tuberculosis (TB)"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://drive.google.com/uc?export=download&id=1-JLqZ7RwZ3VC2d6ErLGHAtOeMRS_7GCz","dataSources":["Krmt6gt9ktB2s6ARh"],"keywords":["oa","based pharmacokinetic modeling (pbpk)","drug","drug interactions (ddi)","fund_not_ack","human immunodeficiency virus (hiv)","lopinavir (lpv)","original","pediatric","physiologically","rifampicin","ritonavir (rtv)","tuberculosis (tb)"],"search_terms":["leveraging","physiologically","based","pharmacokinetic","pbpk","modeling","optimize","dosing","lopinavir","ritonavir","rifampin","pediatric","patients","salerno","capparelli","mcilleron","gerhart","dumond","kashuba","denti","gonzalez"],"title":"Leveraging physiologically‐based pharmacokinetic ( PBPK) modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients","year":2022}